Homburger advised the managers in connection with a private placement of newly issued shares in Basilea Pharmaceutica
On February 24, 2021, Basilea Pharmaceutica, a commercial-stage biopharmaceutical company headquartered in Switzerland and listed on SIX Swiss Exchange, and each of Cantor Fitzgerald & Co., Credit Suisse AG, Bryan, Garnier & Co. Ltd and Bryan Garnier Securities SAS as managers announced a private placement of newly issued Basilea shares, raising gross proceeds of approximately CHF 45.8 m. The new shares, which account for approximately 7.7% of Basilea’s share capital, were placed with institutional investors by way of an accelerated bookbuilding procedure.
The team
Homburger acted as legal counsel to the managers on this transaction with respect to all aspects of Swiss law. The team comprised partner Dieter Gericke and associate Lorenzo Togni (both Corporate / M&A, Capital Markets).
